ReP USP - Resultado da busca

Filtros : "FLAVIVIRIDAE" "FCFRP" Removido: "AEDES" Limpar

Filtros

USP affiliated authors
- figueiredo, luiz tadeu moraes (~1)
- lanchote, vera lucia (~1)
- pippa, leandro francisco (~1)
- quintana, victor hugo aquino (~1)
- rocha, adriana (~1)
Date published
- 2021 (~1)
- 2017 (~1)
Subjects
- flaviviridae (2)
- antivirais (1)
- citocromo p-450 (1)
- clonagem (1)
- dna complementar (1)

Indexado em
- indexado no biosis (1)
- indexado no cab abstracts (1)
- indexado no embase (1)
- indexado no medline (1)
- indexado no scopus (1)

Artigo de periodico
Clinical treatment for hepatitis C reverses CYP2C19 inhibition (2021)
Pippa, Leandro Francisco ; Vieira, Carolina Pinto; Caris, Juciene Aparecida; Rocha, Adriana; Garcia, Camile Prates; Rezende, Rosamar Eulira Fontes; Lanchote, Vera Lucia
Source: British Journal of Clinical Pharmacology. Unidade: FCFRP
Subjects: ANTIVIRAIS, CITOCROMO P-450, FLAVIVIRIDAE, HEPATITE C, HEPATITE CRÔNICA, FARMACOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIPPA, Leandro Francisco et al. Clinical treatment for hepatitis C reverses CYP2C19 inhibition. British Journal of Clinical Pharmacology, v. 87, n. 10, p. 4013-4019, 2021Tradução . . Disponível em: https://doi.org/10.1111/bcp.14829. Acesso em: 11 nov. 2024.
APA
Pippa, L. F., Vieira, C. P., Caris, J. A., Rocha, A., Garcia, C. P., Rezende, R. E. F., & Lanchote, V. L. (2021). Clinical treatment for hepatitis C reverses CYP2C19 inhibition. British Journal of Clinical Pharmacology, 87( 10), 4013-4019. doi:10.1111/bcp.14829
NLM
Pippa LF, Vieira CP, Caris JA, Rocha A, Garcia CP, Rezende REF, Lanchote VL. Clinical treatment for hepatitis C reverses CYP2C19 inhibition [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 10): 4013-4019.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1111/bcp.14829
Vancouver
Pippa LF, Vieira CP, Caris JA, Rocha A, Garcia CP, Rezende REF, Lanchote VL. Clinical treatment for hepatitis C reverses CYP2C19 inhibition [Internet]. British Journal of Clinical Pharmacology. 2021 ; 87( 10): 4013-4019.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1111/bcp.14829
Artigo de periodico
Chimeric viruses between Rocio and West Nile: the role for Rocio prM-E proteins in virulence and inhibition of interferon-α/β signalin (2017)
Amarilla, Alberto A.; Setoh, Yin X.; Periasamy, Parthiban; Peng, Nias Y.; Pali, Gabor; Figueiredo, Luiz Tadeu Moraes; Khromykh, Alexander A.; Aquino, Victor Hugo
Source: Scientific Reports. Unidades: FMRP, FCFRP
Subjects: CLONAGEM, DNA COMPLEMENTAR, FLAVIVIRIDAE, INTERFERONS, PROTEÍNAS QUINASES, VIRULÊNCIA, REPLICAÇÃO VIRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMARILLA, Alberto A. et al. Chimeric viruses between Rocio and West Nile: the role for Rocio prM-E proteins in virulence and inhibition of interferon-α/β signalin. Scientific Reports, v. 7, n. 1, 2017Tradução . . Disponível em: https://doi.org/10.1038/srep44642. Acesso em: 11 nov. 2024.
APA
Amarilla, A. A., Setoh, Y. X., Periasamy, P., Peng, N. Y., Pali, G., Figueiredo, L. T. M., et al. (2017). Chimeric viruses between Rocio and West Nile: the role for Rocio prM-E proteins in virulence and inhibition of interferon-α/β signalin. Scientific Reports, 7( 1). doi:10.1038/srep44642
NLM
Amarilla AA, Setoh YX, Periasamy P, Peng NY, Pali G, Figueiredo LTM, Khromykh AA, Aquino VH. Chimeric viruses between Rocio and West Nile: the role for Rocio prM-E proteins in virulence and inhibition of interferon-α/β signalin [Internet]. Scientific Reports. 2017 ; 7( 1):[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/srep44642
Vancouver
Amarilla AA, Setoh YX, Periasamy P, Peng NY, Pali G, Figueiredo LTM, Khromykh AA, Aquino VH. Chimeric viruses between Rocio and West Nile: the role for Rocio prM-E proteins in virulence and inhibition of interferon-α/β signalin [Internet]. Scientific Reports. 2017 ; 7( 1):[citado 2024 nov. 11 ] Available from: https://doi.org/10.1038/srep44642

Digital Library of Intellectual Production of Universidade de São Paulo 2012 - 2024